(Allergan plc)

	AGN latest price $189.3458 (-0.44%) ($186.2766 - $190.9673) on Fri. May. 9, 2014.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.15% (three month average)
RSI	44
Latest Price	$189.3458(-0.44%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.6% a day on average for past five trading days.
Weekly Trend	AGN declines -0.3% a week on average for past two weeks.
Market Behavior	Normal for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(55%)    XBI(46%)    SPY(43%)    QQQ(42%)    VT(42%)
Factors Impacting AGN price	AGN will decline at least -1.075% in a week (0% probabilities).   TLT(-18%)    SHY(-8%)    IGOV(-6%)    GLD(-6%)    TIP(-4%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.075% (StdDev 2.15%)
Hourly BBV	0 ()
Intraday Trend	0.1%

Resistance Level	$193.03
5 Day Moving Average	$194.25(-2.52%)
10 Day Moving Average	$194.49(-2.64%)
20 Day Moving Average	$193.03(-1.91%)
To recent high	-10.3%
To recent low	3.9%
Market Cap	$62.427b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed